Unituxin is a monoclonal antibody that targets the GD2 antigen present on neuroblastoma cells. Unituxin is one of the therapies used to treat children with high-risk neuroblastoma, a cancer that arises from immature nerve cells.

We developed the 3D style for "How Unituxin Works" -- a video for parents and caregivers, designed in collaboration with the agency Dagr Nott & Associates.
Antibody -- style development
Neuroblastoma tumor cell and GD2 antigens -- style development
Immune cells and Neuroblastoma cells -- style development
Threatening cell -- targeted by the immune system
Antibody and GD2 Antigen interaction
Neuron and GD2 Antigen -- style development
Back to Top